PHIO
Price
$0.83
Change
+$0.03 (+3.75%)
Updated
May 9, 11:31 AM EST
TPST
Price
$3.50
Change
+$0.03 (+0.86%)
Updated
May 9, 9:35 AM EST
Earnings call today
Ad is loading...

PHIO vs TPST

Header iconPHIO vs TPST Comparison
Open Charts PHIO vs TPSTBanner chart's image
Phio Pharmaceuticals
Price$0.83
Change+$0.03 (+3.75%)
Volume$2K
CapitalizationN/A
Tempest Therapeutics
Price$3.50
Change+$0.03 (+0.86%)
Volume$400
CapitalizationN/A
View a ticker or compare two or three
PHIO vs TPST Comparison Chart

Loading...

PHIODaily Signal changed days agoGain/Loss if shorted
 
Show more...
TPSTDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
PHIO vs. TPST commentary
May 09, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PHIO is a Hold and TPST is a Hold.

COMPARISON
Comparison
May 09, 2024
Stock price -- (PHIO: $0.80 vs. TPST: $3.47)
Brand notoriety: PHIO and TPST are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PHIO: 36% vs. TPST: 28%
Market capitalization -- PHIO: $3.67M vs. TPST: $77.09M
PHIO [@Biotechnology] is valued at $3.67M. TPST’s [@Biotechnology] market capitalization is $77.09M. The market cap for tickers in the [@Biotechnology] industry ranges from $567.57B to $0. The average market capitalization across the [@Biotechnology] industry is $2.65B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PHIO’s FA Score shows that 0 FA rating(s) are green whileTPST’s FA Score has 0 green FA rating(s).

  • PHIO’s FA Score: 0 green, 5 red.
  • TPST’s FA Score: 0 green, 5 red.
According to our system of comparison, both PHIO and TPST are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PHIO’s TA Score shows that 5 TA indicator(s) are bullish while TPST’s TA Score has 3 bullish TA indicator(s).

  • PHIO’s TA Score: 5 bullish, 4 bearish.
  • TPST’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, PHIO is a better buy in the short-term than TPST.

Price Growth

PHIO (@Biotechnology) experienced а +5.10% price change this week, while TPST (@Biotechnology) price change was -4.14% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.58%. For the same industry, the average monthly price growth was -4.35%, and the average quarterly price growth was +71.86%.

Reported Earning Dates

PHIO is expected to report earnings on May 11, 2023.

TPST is expected to report earnings on Aug 12, 2024.

Industries' Descriptions

@Biotechnology (+0.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for PHIO with price predictions.
OPEN
A.I.dvisor published
a Summary for TPST with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
TPST($77.1M) has a higher market cap than PHIO($3.67M). PHIO YTD gains are higher at: 5.263 vs. TPST (-21.136).
PHIOTPSTPHIO / TPST
Capitalization3.67M77.1M5%
EBITDAN/AN/A-
Gain YTD5.263-21.136-25%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
PHIO vs TPST: Fundamental Ratings
PHIO
TPST
OUTLOOK RATING
1..100
341
VALUATION
overvalued / fair valued / undervalued
1..100
62
Fair valued
52
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9899
PRICE GROWTH RATING
1..100
4948
P/E GROWTH RATING
1..100
10086
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TPST's Valuation (52) in the Pharmaceuticals Major industry is in the same range as PHIO (62) in the Biotechnology industry. This means that TPST’s stock grew similarly to PHIO’s over the last 12 months.

TPST's Profit vs Risk Rating (100) in the Pharmaceuticals Major industry is in the same range as PHIO (100) in the Biotechnology industry. This means that TPST’s stock grew similarly to PHIO’s over the last 12 months.

PHIO's SMR Rating (98) in the Biotechnology industry is in the same range as TPST (99) in the Pharmaceuticals Major industry. This means that PHIO’s stock grew similarly to TPST’s over the last 12 months.

TPST's Price Growth Rating (48) in the Pharmaceuticals Major industry is in the same range as PHIO (49) in the Biotechnology industry. This means that TPST’s stock grew similarly to PHIO’s over the last 12 months.

TPST's P/E Growth Rating (86) in the Pharmaceuticals Major industry is in the same range as PHIO (100) in the Biotechnology industry. This means that TPST’s stock grew similarly to PHIO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
PHIOTPST
RSI
ODDS (%)
N/A
Bearish Trend 7 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
78%
MACD
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
87%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
87%
Advances
ODDS (%)
Bullish Trend 7 days ago
82%
Bullish Trend 4 days ago
81%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
View a ticker or compare two or three
Ad is loading...
PHIODaily Signal changed days agoGain/Loss if shorted
 
Show more...
TPSTDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ORGN1.210.11
+10.00%
Origin Materials
SJW56.670.72
+1.29%
SJW Group
PCVX66.79-0.73
-1.08%
Vaxcyte
GOOGL169.38-1.87
-1.09%
Alphabet
CCCC6.45-0.34
-5.01%
C4 Therapeutics

TPST and

Correlation & Price change

A.I.dvisor indicates that over the last year, TPST has been closely correlated with MTNB. These tickers have moved in lockstep 74% of the time. This A.I.-generated data suggests there is a high statistical probability that if TPST jumps, then MTNB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TPST
1D Price
Change %
TPST100%
-4.14%
MTNB - TPST
74%
Closely correlated
+3.80%
PHIO - TPST
49%
Loosely correlated
-4.35%
ORMP - TPST
30%
Poorly correlated
+1.25%
RLAY - TPST
30%
Poorly correlated
-3.41%
SWTX - TPST
30%
Poorly correlated
-7.63%
More